000739:SHE
Apeloa Pharmaceutical Co Ltd
CN¥ २३.४२
arrow_downward
-१.६४%(-०.३९) 1D
अक्टोबर १६, १५:०४:४८ GMT+८ · CNY
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 000739...
Open
CN¥ २४.०४
High
CN¥ २४.७६
Low
CN¥ २३.०९
Mkt. cap
२७.१३ अरब
Avg. vol.
१.६३ करोड
Volume
१.५१ करोड
Dividend
१.६१%
Quarterly dividend
CN¥ ०.०९
Ex-dividend date
२०२६ अक्टोबर ८
P/E ratio
३१.७८
52-wk high
CN¥ २८.५०
52-wk low
CN¥ १४.८९
EPS
CN¥ ०.७४
Shares outstanding
१.१६ अरब
No. of employees
७ हजार
Open
CN¥ २४.०४
High
CN¥ २४.७६
Low
CN¥ २३.०९
Mkt. cap
२७.१३ अरब
Avg. vol.
१.६३ करोड
Volume
१.५१ करोड
Dividend
१.६१%
Quarterly dividend
CN¥ ०.०९
Ex-dividend date
२०२६ अक्टोबर ८
P/E ratio
३१.७८
52-wk high
CN¥ २८.५०
52-wk low
CN¥ १४.८९
EPS
CN¥ ०.७४
Shares outstanding
१.१६ अरब
No. of employees
७ हजार
News stories
From web sources and news partners
Simply Wall Street
·
४० मिनेट पहिले
Warner Music Group (WMG) Draws Fresh Interest, Is A 17% Discount Still On Offer?
The Motley Fool
·
२५ मिनेट पहिले
Should You Invest in the S&P 500 Right Now or Wait? There's 1 Clear Answer
Yahoo Finance
·
४ घण्टा पहिले
Michael Burry Warns Stock Market Could Be Months Away From A 2000-Style Reckoning — ‘The Preconditions Seem Set For Fireworks’
AOL.com
·
४ घण्टा पहिले
Moderna Just Joined the Nasdaq-100. Here's What That Means for Investors.
Profile
Apeloa Pharmaceutical Co., Ltd., known as Apeloa, is a Chinese pharmaceutical manufacturer under Hengdian Group. The company is headquartered in Hengdian, Dongyang, Zhejiang, China. It was founded in 1989 and has been listed on the Shenzhen Stock Exchange since 9 May 1997. Apeloa provides contract development and manufacturing services and manufactures APIs and finished dosage forms; products span cardiovascular, anti-infective, psychiatric and oncology areas.
Apeloa has 7400 employees, 8 manufacturing sites and 3 R&D centers in Boston, Shanghai and Hengdian, covering flow chemistry, synthetic biology and biocatalysis, and peptide development. It has invested over USD20 million in flow chemistry over the past ten years in an effort to advance sustainable pharmaceutical manufacturing. In Boston, its 17,000-square-foot facility does R&D related to chemistry needs in drug development, including preclinical chemistry, scale-up production and new drug development.
Apeloa Pharmaceutical has successfully passed 20 U.S. FDA inspections since 2006. Wikipedia
About Apeloa Pharmaceutical Co Ltd